233 related articles for article (PubMed ID: 23443539)
1. Translation of HTT mRNA with expanded CAG repeats is regulated by the MID1-PP2A protein complex.
Krauss S; Griesche N; Jastrzebska E; Chen C; Rutschow D; Achmüller C; Dorn S; Boesch SM; Lalowski M; Wanker E; Schneider R; Schweiger S
Nat Commun; 2013; 4():1511. PubMed ID: 23443539
[TBL] [Abstract][Full Text] [Related]
2. Protein phosphatase 2A (PP2A)-specific ubiquitin ligase MID1 is a sequence-dependent regulator of translation efficiency controlling 3-phosphoinositide-dependent protein kinase-1 (PDPK-1).
Aranda-Orgillés B; Rutschow D; Zeller R; Karagiannidis AI; Köhler A; Chen C; Wilson T; Krause S; Roepcke S; Lilley D; Schneider R; Schweiger S
J Biol Chem; 2011 Nov; 286(46):39945-57. PubMed ID: 21930711
[TBL] [Abstract][Full Text] [Related]
3. Reducing Mutant Huntingtin Protein Expression in Living Cells by a Newly Identified RNA CAG Binder.
Matthes F; Massari S; Bochicchio A; Schorpp K; Schilling J; Weber S; Offermann N; Desantis J; Wanker E; Carloni P; Hadian K; Tabarrini O; Rossetti G; Krauss S
ACS Chem Neurosci; 2018 Jun; 9(6):1399-1408. PubMed ID: 29506378
[TBL] [Abstract][Full Text] [Related]
4. Regulation of mRNA Translation by MID1: A Common Mechanism of Expanded CAG Repeat RNAs.
Griesche N; Schilling J; Weber S; Rohm M; Pesch V; Matthes F; Auburger G; Krauss S
Front Cell Neurosci; 2016; 10():226. PubMed ID: 27774050
[TBL] [Abstract][Full Text] [Related]
5. Active transport of the ubiquitin ligase MID1 along the microtubules is regulated by protein phosphatase 2A.
Aranda-Orgillés B; Aigner J; Kunath M; Lurz R; Schneider R; Schweiger S
PLoS One; 2008; 3(10):e3507. PubMed ID: 18949047
[TBL] [Abstract][Full Text] [Related]
6. The MID1 Protein: A Promising Therapeutic Target in Huntington's Disease.
Heinz A; Schilling J; van Roon-Mom W; Krauß S
Front Genet; 2021; 12():761714. PubMed ID: 34659371
[TBL] [Abstract][Full Text] [Related]
7. Control of mTORC1 signaling by the Opitz syndrome protein MID1.
Liu E; Knutzen CA; Krauss S; Schweiger S; Chiang GG
Proc Natl Acad Sci U S A; 2011 May; 108(21):8680-5. PubMed ID: 21555591
[TBL] [Abstract][Full Text] [Related]
8. Msh2 acts in medium-spiny striatal neurons as an enhancer of CAG instability and mutant huntingtin phenotypes in Huntington's disease knock-in mice.
Kovalenko M; Dragileva E; St Claire J; Gillis T; Guide JR; New J; Dong H; Kucherlapati R; Kucherlapati MH; Ehrlich ME; Lee JM; Wheeler VC
PLoS One; 2012; 7(9):e44273. PubMed ID: 22970194
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of RNA-induced toxicity in CAG repeat disorders.
Nalavade R; Griesche N; Ryan DP; Hildebrand S; Krauss S
Cell Death Dis; 2013 Aug; 4(8):e752. PubMed ID: 23907466
[TBL] [Abstract][Full Text] [Related]
10. The E3 ubiquitin ligase MID1 catalyzes ubiquitination and cleavage of Fu.
Schweiger S; Dorn S; Fuchs M; Köhler A; Matthes F; Müller EC; Wanker E; Schneider R; Krauß S
J Biol Chem; 2014 Nov; 289(46):31805-31817. PubMed ID: 25278022
[TBL] [Abstract][Full Text] [Related]
11. Mutant CAG repeats of Huntingtin transcript fold into hairpins, form nuclear foci and are targets for RNA interference.
de Mezer M; Wojciechowska M; Napierala M; Sobczak K; Krzyzosiak WJ
Nucleic Acids Res; 2011 May; 39(9):3852-63. PubMed ID: 21247881
[TBL] [Abstract][Full Text] [Related]
12. Early Neurodegeneration in R6/2 Mice Carrying the Huntington's Disease Mutation with a Super-Expanded CAG Repeat, Despite Normal Lifespan.
Kielar C; Morton AJ
J Huntingtons Dis; 2018; 7(1):61-76. PubMed ID: 29480204
[TBL] [Abstract][Full Text] [Related]
13. A pathogenic mechanism in Huntington's disease involves small CAG-repeated RNAs with neurotoxic activity.
Bañez-Coronel M; Porta S; Kagerbauer B; Mateu-Huertas E; Pantano L; Ferrer I; Guzmán M; Estivill X; Martí E
PLoS Genet; 2012; 8(2):e1002481. PubMed ID: 22383888
[TBL] [Abstract][Full Text] [Related]
14. Investigations of Huntington's Disease and Huntington's Disease-Like Syndromes in Indian Choreatic Patients.
Kaur J; Parveen S; Shamim U; Sharma P; Suroliya V; Sonkar AK; Ahmad I; Garg J; Anand KS; Laskar S; Chowdhury D; Kushwaha S; Goyal V; Srivastava AK; Singh G; Faruq M
J Huntingtons Dis; 2020; 9(3):283-289. PubMed ID: 32675418
[TBL] [Abstract][Full Text] [Related]
15. RNA toxicity induced by expanded CAG repeats in Huntington's disease.
Martí E
Brain Pathol; 2016 Nov; 26(6):779-786. PubMed ID: 27529325
[TBL] [Abstract][Full Text] [Related]
16. TRAIL signals through the ubiquitin ligase MID1 to promote pulmonary fibrosis.
Collison AM; Li J; de Siqueira AP; Lv X; Toop HD; Morris JC; Starkey MR; Hansbro PM; Zhang J; Mattes J
BMC Pulm Med; 2019 Feb; 19(1):31. PubMed ID: 30732588
[TBL] [Abstract][Full Text] [Related]
17. Parent-of-origin differences of mutant HTT CAG repeat instability in Huntington's disease.
Aziz NA; van Belzen MJ; Coops ID; Belfroid RD; Roos RA
Eur J Med Genet; 2011; 54(4):e413-8. PubMed ID: 21540131
[TBL] [Abstract][Full Text] [Related]
18. Nuclear retention of full-length HTT RNA is mediated by splicing factors MBNL1 and U2AF65.
Sun X; Li PP; Zhu S; Cohen R; Marque LO; Ross CA; Pulst SM; Chan HY; Margolis RL; Rudnicki DD
Sci Rep; 2015 Jul; 5():12521. PubMed ID: 26218986
[TBL] [Abstract][Full Text] [Related]
19. Autopsy-proven Huntington's disease with 29 trinucleotide repeats.
Kenney C; Powell S; Jankovic J
Mov Disord; 2007 Jan; 22(1):127-30. PubMed ID: 17115386
[TBL] [Abstract][Full Text] [Related]
20. Allele-selective inhibition of mutant huntingtin expression with antisense oligonucleotides targeting the expanded CAG repeat.
Gagnon KT; Pendergraff HM; Deleavey GF; Swayze EE; Potier P; Randolph J; Roesch EB; Chattopadhyaya J; Damha MJ; Bennett CF; Montaillier C; Lemaitre M; Corey DR
Biochemistry; 2010 Nov; 49(47):10166-78. PubMed ID: 21028906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
